KLOW, GLOW and Wolverine are not three strengths of the same product — they are three different component sets, and the milligram figure on the label describes total solid rather than anything about the ratio between components. Working out what is actually in a blend vial, and what that means analytically, is a short exercise in arithmetic that most descriptions skip.
What is in each
| Blend | Components | Catalogue presentation | Number of distinct molecules |
|---|---|---|---|
| Wolverine | BPC-157 + TB-500 | 10 mg (5/5) and 20 mg (10/10) | 2 |
| GLOW | BPC-157 + TB-500 + GHK-Cu | 70 mg total | 3 |
| KLOW | BPC-157 + TB-500 + GHK-Cu + KPV | 80 mg total | 4 |
| Wolverine Stack | BPC-157, TB-500, GHK-Cu as three separate vials | 3-vial stack | 3, independently reconstituted |
Wolverine is the simple case: a 1:1 co-formulation of the two most-studied tissue-repair peptides, catalogued as BPC-157 + TB-500. GLOW adds the copper tripeptide; KLOW adds KPV on top of that, and the K in the name is the KPV. The naming convention is essentially additive, which is why the total masses climb from 10–20 mg to 70 mg to 80 mg — most of that increase is the copper peptide, for reasons that are about molecular weight rather than emphasis.
Why the mass ratio misleads
The four component molecules span an unusually wide molecular-weight range for a single vial:
| Component | Molecular weight | µmol per 10 mg |
|---|---|---|
| BPC-157 | 1,419.55 Da | ≈ 7.0 |
| TB-500 (heptapeptide) | 889.02 Da | ≈ 11.2 |
| GHK-Cu | 403.93 Da | ≈ 24.8 |
| KPV | 342.43 Da | ≈ 29.2 |
A GHK-Cu-heavy blend therefore contains far more molecules of copper peptide than the mass fraction suggests. Take a 70 mg GLOW vial composed of, say, 10 mg BPC-157, 10 mg TB-500 and 50 mg GHK-Cu: that is roughly 7.0 µmol, 11.2 µmol and 123.8 µmol respectively. By mass the copper peptide is about 71% of the vial; by molar quantity it is about 87% of the molecules present. Any interpretation framed in terms of receptor occupancy or signalling stoichiometry has to use the molar column, not the label.
The same applies to KPV — a tripeptide of 342.43 Da, the smallest molecule in the set, present in high molar quantity relative to its mass share. The general treatment of this arithmetic is in the reconstitution guide.
Reconstitution arithmetic for a blend
A blend has one volume and therefore one dilution factor applied to every component simultaneously — which is convenient and also the source of most confusion. Take an 80 mg KLOW vial reconstituted with 4 mL of solvent. The total solid concentration is 20 mg/mL, but no single component is at 20 mg/mL. If the vial were composed of 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu and 10 mg KPV, the reconstituted concentrations are 2.5, 2.5, 12.5 and 2.5 mg/mL respectively. In molar terms that is roughly 1.76 mM, 2.81 mM, 30.9 mM and 7.30 mM — a spread of more than seventeen-fold across components in the same solution.
Two habits keep this straight. Record concentrations per component rather than for the vial as a whole, and always carry the molar figure alongside the mass figure. A laboratory notebook entry that says "KLOW 20 mg/mL" is not a usable record; one that lists four components with their individual mass and molar concentrations is.
Chemical compatibility inside one vial
Co-formulating a copper complex with other peptides raises a legitimate compatibility question, and here the sequences answer it favourably. BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val: no methionine, no cysteine, no tryptophan. TB-500 is Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln: same absences. KPV is Lys-Pro-Val: three residues, none of them oxidation-prone. The residues most vulnerable to copper-catalysed oxidation are simply not present in any of the partners, which is a genuinely good reason why this particular combination is chemically sensible rather than merely commercially convenient.
What does still apply is pH and chelation. The copper complex's stability depends on its coordination environment, so reconstitution solvent choice matters more for a copper-containing blend than for a plain peptide blend, and the blue colour of the reconstituted solution is a free indicator that the complex is intact.
Reading a multi-component certificate of analysis
This is where blends separate credible suppliers from careless ones. A single purity percentage for a four-component vial is not a meaningful statement — purity relative to what? A blend COA should show:
- A chromatogram in which every component resolves as its own peak, with retention times stated.
- An individual purity figure for each component, ideally with the method conditions that produced the separation.
- Mass-spectrometric identity confirmation for each component — four expected masses for KLOW, not one.
- A content or ratio assay stating how much of each component is present, not just that all are present.
The GHK-Cu peak is a useful sanity check here, because a copper complex behaves distinctly on reversed-phase chromatography and its expected mass of 403.93 Da is far from the others. If a blend COA shows a single peak or a single mass, it is describing something other than the vial in front of you. Method detail is in how to read a peptide COA.
Blend versus separate vials
The trade-off is straightforward. A blend fixes the ratio, uses one reconstitution volume and one set of arithmetic, and is convenient when the design calls for a fixed composition. Separate vials — the approach taken by the Wolverine Stack, which supplies three peptides as three independent vials — preserve the ability to vary one component while holding others constant, which is what any question about relative contribution actually requires.
In practice, replication work favours blends and mechanistic work favours separate vials. The broader argument is set out in peptide blends vs single vials, and the direct comparison of the two most-confused blends is in KLOW blend vs GLOW blend. The category sits in recovery blends.
The practical summary
Read a blend label as a statement of total solid, then immediately convert to molar quantities per component. Check the COA resolves and identifies every component individually. Note that the low-molecular-weight components dominate the molecule count regardless of what the mass fractions look like. And treat named blends as compositions to be verified rather than brands to be trusted — the names are catalogue conventions, and the chemistry is what you can actually check.